학술논문
Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: Results of a randomized, placebo-controlled trial
Document Type
Article
Author
Rissanen, A.; Howard, C.P.; Thuren, T.; Botha, J.; Proietto, J.; Nicholson, G.; Colman, P.; Aronson, R.; Goldenberg, R.; Khandwala, H.; Dumas, R.; Hallé, J.-P.; Rissanen, A.; Keinanen-Kiukaanniemi, S.; Laine, M.; Anderten, H.; Boeckmann, U.; Chevts, J.; Keuthage, W.; Funke, K.; Khariouzov, A.; Luedemann, J.; Martin, S.; Rau, T.; Schneider, R.; Steinmaier, G.; Venschott-Jordan, U.; Zeissig, I.; Jain, S.; Dharskar, A.; Reddy, S.; Srikanta, S.; Subrahmanyam, K.; Mohan, V.; Nair, R.K.; Kale, S.; Dotta, F.; Pontiroli, A.; Pagani, G.; Giaccari, A.; Ronchi, E.; Piatti, P.; Viviani, G.L.; Anderson, R.; Arena, C.M.; Burton, R.; Lane, J.; Lewin, A.; Lillestol, M.; Mitchell, J.R.; Palchick, B.; Rosenstock, J.; Wittmer, B.; Lipetz, R.
Source
In: Diabetes, Obesity and Metabolism . (Diabetes, Obesity and Metabolism, December 2012, 14(12):1088-1096)
Subject
Language
English
ISSN
14631326
14628902
14628902